Skip to content

Aptose Biosciences Inc.

APTOF

CIK 0000882361

← back to feed
Revenue (TTM)
$0
Q1 May 2026
Net Income (TTM)
−$25.34M
−0.1% YoY Q1 May 2026
EPS Diluted (TTM)
−$10.37
+71.4% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$24.84M
Q1 May 2026
Cash
$935K
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
2.55M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings